PB Ratio: 1.98

Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/B ratio high or low?

The P/B ratio of 1.98 is 22% above its estimated 2-year average of 1.62, around the middle of its estimated 2-year range (0.48–2.75).

As of 2026-10-06T19:11:24.817Z. 1.24% above its estimated 12-month average of 1.96.

CTNM PB Ratio Metrics

P/B vs. estimated history

At 1.98, P/B is above its estimated 2-year median — higher than 70% of readings in its estimated 2-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Book Value Analysis

PB Ratio Formula & Definition

PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)

The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PB Ratio FAQ

What is the P/B ratio for Contineum Therapeutics, Inc. (CTNM)?

The P/B ratio for CTNM stock is 1.98.

Is Contineum Therapeutics, Inc.'s P/B ratio high or low?

The P/B ratio of 1.98 is 22% above its estimated 2-year average of 1.62, around the middle of its estimated 2-year range (0.48–2.75).

What is the estimated TTM average P/B ratio for Contineum Therapeutics, Inc. (CTNM)?

The estimated TTM average P/B ratio for CTNM stock is 1.96.

Showing the most recent 260 of 536 data points. The chart above shows the full history.

Related Metrics